JMC and Insilico Medicine Introduce Innovative AI-Powered FGFR2/3 Inhibitor to Tackle Resistance Due to Tumor Mutations
In recent groundbreaking research, Insilico Medicine has pushed the boundaries of drug discovery with the development of a pioneering and ...
